Literature DB >> 8483915

Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.

L Fananapazir1, M C Dalakas, F Cyran, G Cohn, N D Epstein.   

Abstract

Hypertrophic cardiomyopathy (HCM) is an important cause of sudden death in apparently healthy young individuals. In less than half of kindreds with HCM, the disease is linked to the beta-myosin heavy-chain gene locus (MYH7). We have recently described two missense MYH7 gene mutations [Arg-403 to Gln (R403Q) and Leu-908 to Val (L908V)] and found that the mutant message is present in skeletal muscle soleus) and that the mutant beta-myosin obtained from soleus muscle has abnormal in vitro motility activity. Having identified a second kindred with the R403Q mutation, and 3 other kindreds with two additional mutations (G741R and G256E), we performed histochemical analysis of soleus muscle biopsies from 25 HCM patients with one of these four mutations. Light microscopic examination of the NADH-stained biopsies revealed the presence of central core disease (CCD) of skeletal muscle, a rare autosomal dominant nonprogressive myopathy characterized by a predominance of type I "slow" fibers and an absence of mitochondria in the center of many type I fibers. CCD was present in 10 of 13 patients with the L908V mutation, 5 of 8 patients with the R403Q mutation, 1 of 3 patients with the G741R mutation, and 1 patient with the G256E mutation. Mild-to-moderate myopathic changes with muscle fiber hypertrophy were present in 16 patients. Notably, CCD was present in 2 adults and 3 children with the L908V mutation who did not have cardiac hypertrophy. In contrast, soleus muscle samples from 5 patients from 4 kindreds in which HCM was not linked to the MYH7 locus showed no myopathy or CCD. Soleus muscle biopsies from 5 control subjects also showed normal histology. This work demonstrates that (i) MYH7-associated HCM is often a disease of striated muscle but with predominant cardiac involvement and (ii) a subset of HCM patients with MYH7 gene missense mutations have CCD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483915      PMCID: PMC46432          DOI: 10.1073/pnas.90.9.3993

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Central core disease: ultrastructure of the sarcoplasmic reticulum and T-tubules.

Authors:  K Hayashi; R G Miller; A K Brownell
Journal:  Muscle Nerve       Date:  1989-02       Impact factor: 3.217

2.  Affinity generation of single-stranded DNA for dideoxy sequencing following the polymerase chain reaction.

Authors:  L G Mitchell; C R Merril
Journal:  Anal Biochem       Date:  1989-05-01       Impact factor: 3.365

3.  Data on the distribution of fibre types in thirty-six human muscles. An autopsy study.

Authors:  M A Johnson; J Polgar; D Weightman; D Appleton
Journal:  J Neurol Sci       Date:  1973-01       Impact factor: 3.181

4.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

5.  Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated.

Authors:  A M Lompré; B Nadal-Ginard; V Mahdavi
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

6.  Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem.

Authors:  V Mahdavi; A P Chambers; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Expression of rabbit ventricular alpha-myosin heavy chain messenger RNA sequences in atrial muscle.

Authors:  A M Sinha; D J Friedman; J M Nigro; S Jakovcic; M Rabinowitz; P K Umeda
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

8.  Central core disease. Study of a family with five affected generations.

Authors:  E Byrne; P C Blumbergs; J F Hallpike
Journal:  J Neurol Sci       Date:  1982-01       Impact factor: 3.181

9.  Voluntary muscle involvement in hypertrophic cardiomyopathy. A study of eleven patients.

Authors:  E R Smith; L P Heffernan; V E Sangalang; L M Vaughan; C S Flemington
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

10.  Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Authors:  L Fananapazir; A C Chang; S E Epstein; D McAreavey
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

View more
  52 in total

Review 1.  Heart mitochondria signaling pathways: appraisal of an emerging field.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

2.  Clinical utility gene card for: Multi-minicore disease.

Authors:  Suzanne Lillis; Steve Abbs; Ana Ferreiro; Francesco Muntoni; Heinz Jungbluth
Journal:  Eur J Hum Genet       Date:  2011-10-19       Impact factor: 4.246

3.  Clinical utility gene card for: Central core disease.

Authors:  Suzanne Lillis; Stephen Abbs; Clemens R Mueller; Francesco Muntoni; Heinz Jungbluth
Journal:  Eur J Hum Genet       Date:  2011-10-12       Impact factor: 4.246

4.  Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy.

Authors:  C H Thompson; G J Kemp; D J Taylor; M Conway; B Rajagopalan; A O'Donoghue; P Styles; W J McKenna; G K Radda
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

5.  Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.

Authors:  Sarah R Clippinger; Paige E Cloonan; Lina Greenberg; Melanie Ernst; W Tom Stump; Michael J Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

6.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

7.  Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.

Authors:  Saidi A Mohiddin; Lameh Fananapazir
Journal:  Tex Heart Inst J       Date:  2002

8.  The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; N D Epstein; J R Sellers
Journal:  J Muscle Res Cell Motil       Date:  1997-06       Impact factor: 2.698

Review 9.  Congenital myopathies.

Authors:  Claudio Bruno; Carlo Minetti
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

10.  Laing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsy.

Authors:  P J Lamont; B Udd; F L Mastaglia; M de Visser; P Hedera; T Voit; L R Bridges; V Fabian; A Rozemuller; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.